Able View Global Inc. (NASDAQ:ABLV - Get Free Report) was the target of a large decline in short interest in May. As of May 15th, there was short interest totalling 45,100 shares, a decline of 20.2% from the April 30th total of 56,500 shares. Approximately 0.5% of the company's stock are sold short. Based on an average trading volume of 127,800 shares, the short-interest ratio is currently 0.4 days.
Able View Global Price Performance
Shares of Able View Global stock traded down $0.01 on Tuesday, hitting $1.23. 5,379 shares of the company traded hands, compared to its average volume of 49,437. Able View Global has a 12-month low of $0.55 and a 12-month high of $1.90. The company has a current ratio of 2.11, a quick ratio of 1.41 and a debt-to-equity ratio of 0.49. The company has a 50-day moving average price of $1.11 and a 200 day moving average price of $0.98.
Able View Global Company Profile
(
Get Free Report)
Able View Global Inc operates as brand management partners of beauty and personal care brands in China. Its brand management services encompass various segments of the brand management value chain, including strategy, branding, digital and social marketing, omni-channel sales, customer services, overseas logistics, and warehouse and fulfilment.
Read More
Before you consider Able View Global, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Able View Global wasn't on the list.
While Able View Global currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.